{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:28:39Z","timestamp":1794360519239,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82202065"],"award-info":[{"award-number":["82202065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nanjing Health Science and Technology Development Special Fund","award":["YKK21159"],"award-info":[{"award-number":["YKK21159"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12035-024-04235-z","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T09:01:51Z","timestamp":1716195711000},"page":"10645-10655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Creatine Kinase-MM\/Proto-oncogene Tyrosine-Protein Kinase Receptor as a Sensitive Indicator for Duchenne Muscular Dystrophy Carriers"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9336-1769","authenticated-orcid":false,"given":"Zhilei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9486-1615","authenticated-orcid":false,"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,20]]},"reference":[{"issue":"12","key":"4235_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/s1474-4422(03)00585-4","volume":"2","author":"F Muntoni","year":"2003","unstructured":"Muntoni F, Torelli S, Ferlini A (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2(12):731\u2013740. https:\/\/doi.org\/10.1016\/s1474-4422(03)00585-4","journal-title":"Lancet Neurol"},{"issue":"3","key":"4235_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"DMD Care Considerations Working Group, Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 17(3):251\u2013267. https:\/\/doi.org\/10.1016\/S1474-4422(18)30024-3","journal-title":"Lancet Neurol"},{"issue":"2","key":"4235_CR3","doi-asserted-by":"publisher","first-page":"dmm043638","DOI":"10.1242\/dmm.043638","volume":"13","author":"MD Grounds","year":"2020","unstructured":"Grounds MD, Terrill JR, Al-Mshhdani BA, Duong MN, Radley-Crabb HG, Arthur PG (2020) Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress. Dis Model Mech 13(2):dmm043638. https:\/\/doi.org\/10.1242\/dmm.043638","journal-title":"Dis Model Mech"},{"issue":"3","key":"4235_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.23528","volume":"71","author":"JR Mendell","year":"2012","unstructured":"Mendell JR, Shilling C, Leslie ND, Flanigan KM, Al-Dahhak R, Gastier-Foster J, Kneile K, Dunn DM, Duval B, Aoyagi A, Hamil C, Mahmoud M, Roush K, Bird L, Rankin C, Lilly H, Street N, Chandrasekar R, Weiss RB (2012) Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol 71(3):304\u2013313. https:\/\/doi.org\/10.1002\/ana.23528","journal-title":"Ann Neurol"},{"issue":"4","key":"4235_CR5","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1373\/clinchem.2016.268425","volume":"63","author":"SJ Moat","year":"2017","unstructured":"Moat SJ, Korpimaki T, Furu P, Hakala H, Polari H, Merio L, Makinen P, Weeks I (2017) Characterization of a blood spot creatine kinase skeletal muscle isoform immunoassay for high-throughput newborn screening of Duchenne muscular dystrophy. Clin Chem 63(4):908\u2013914. https:\/\/doi.org\/10.1373\/clinchem.2016.268425","journal-title":"Clin Chem"},{"issue":"10","key":"4235_CR6","doi-asserted-by":"publisher","first-page":"18168","DOI":"10.3390\/molecules201018168","volume":"20","author":"MS Falzarano","year":"2015","unstructured":"Falzarano MS, Scotton C, Passarelli C, Ferlini A (2015) Duchenne muscular dystrophy: from diagnosis to therapy. Molecules 20(10):18168\u201318184. https:\/\/doi.org\/10.3390\/molecules201018168","journal-title":"Molecules"},{"issue":"3","key":"4235_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12519-017-0036-3","volume":"13","author":"Q Ke","year":"2017","unstructured":"Ke Q, Zhao ZY, Griggs R, Wiley V, Connolly A, Kwon J, Qi M, Sheehan D, Ciafaloni E, Howell RR, Furu P, Sazani P, Narayana A, Gatheridge M (2017) Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment. World J Pediatr 13(3):197\u2013201. https:\/\/doi.org\/10.1007\/s12519-017-0036-3","journal-title":"World J Pediatr"},{"issue":"2","key":"4235_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.24555","volume":"79","author":"JR Mendell","year":"2016","unstructured":"Mendell JR, Goemans N, Lowes LP, Alfano LN, Berry K, Shao J, Kaye EM, Mercuri E (2016) Eteplirsen Study Group Telethon Foundation DMD Italian Network. Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy. Ann Neurol 79(2):257\u2013271. https:\/\/doi.org\/10.1002\/ana.24555","journal-title":"Ann Neurol"},{"issue":"6","key":"4235_CR9","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/mus.25445","volume":"55","author":"T McCaffrey","year":"2017","unstructured":"McCaffrey T, Guglieri M, Murphy AP, Bushby K, Johnson A, Bourke JP (2017) Cardiac involvement in female carriers of Duchenne or Becker muscular dystrophy. Muscle Nerve 55(6):810\u2013818. https:\/\/doi.org\/10.1002\/mus.25445","journal-title":"Muscle Nerve"},{"issue":"7","key":"4235_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nmd.2018.04.005","volume":"28","author":"M Ishizaki","year":"2018","unstructured":"Ishizaki M, Kobayashi M, Adachi K, Matsumura T, Kimura E (2018) Female dystrophinopathy: review of current literature. Neuromuscul Disord 28(7):572\u2013581. https:\/\/doi.org\/10.1016\/j.nmd.2018.04.005","journal-title":"Neuromuscul Disord"},{"issue":"17","key":"4235_CR11","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jama.1996.03530410049032","volume":"275","author":"L Politano","year":"1996","unstructured":"Politano L, Nigro V, Nigro G, Petretta VR, Passamano L, Papparella S, Di Somma S, Comi LI (1996) Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 275(17):1335\u20131338","journal-title":"JAMA"},{"issue":"1","key":"4235_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1212\/WNL.0b013e318221ad14","volume":"77","author":"SM Schade van Westrum","year":"2011","unstructured":"Schade van Westrum SM, Hoogerwaard EM, Dekker L, Standaar TS, Bakker E, Ippel PF, Oosterwijk JC, Majoor-Krakauer DF, van Essen AJ, Leschot NJ, Wilde AA, de Haan RJ, de Visser M, van der Kooi AJ (2011) Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy. Neurology 77(1):62\u201366. https:\/\/doi.org\/10.1212\/WNL.0b013e318221ad14","journal-title":"Neurology"},{"key":"4235_CR13","doi-asserted-by":"publisher","unstructured":"Ayoglu B, Chaouch A, Lochmuller H, Politano L, Bertini E, Spitali P, Hiller M, Niks EH, Gualandi F, Ponten F, Bushby K, Aartsma-Rus A, Schwartz E, Le Priol Y, Straub V, Uhlen M, Cirak S, t Hoen PA, Muntoni F, Ferlini A, Schwenk JM, Nilsson P, Al-Khalili Szigyarto C (2014) Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies. EMBO Mol Med 6(7): 918\u2013936. https:\/\/doi.org\/10.15252\/emmm.201303724.","DOI":"10.15252\/emmm.201303724"},{"issue":"7","key":"4235_CR14","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1038\/mtna.2014.29","volume":"3","author":"X Li","year":"2014","unstructured":"Li X, Li Y, Zhao L, Zhang D, Yao X, Zhang H, Wang YC, Wang XY, Xia H, Yan J, Ying H (2014) Circulating muscle-specific miRNAs in Duchenne muscular dystrophy patients. Mol Ther Nucleic Acids 3(7):e177. https:\/\/doi.org\/10.1038\/mtna.2014.29","journal-title":"Mol Ther Nucleic Acids"},{"key":"4235_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.lfs.2016.01.032","volume":"151","author":"NK Srivastava","year":"2016","unstructured":"Srivastava NK, Annarao S, Sinha N (2016) Metabolic status of patients with muscular dystrophy in early phase of the disease: in vitro, high resolution NMR spectroscopy based metabolomics analysis of serum. Life Sci 151:122\u2013129. https:\/\/doi.org\/10.1016\/j.lfs.2016.01.032","journal-title":"Life Sci"},{"issue":"1","key":"4235_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/jamaneurol.2015.3537","volume":"73","author":"MA Gatheridge","year":"2016","unstructured":"Gatheridge MA, Kwon JM, Mendell JM, Scheuerbrandt G, Moat SJ, Eyskens F, Rockman-Greenberg C, Drousiotou A, Griggs RC (2016) Identifying non\u2013Duchenne muscular dystrophy\u2013positive and false negative results in prior Duchenne muscular dystrophy newborn screening programs. JAMA Neurol 73(1):111\u2013116. https:\/\/doi.org\/10.1001\/jamaneurol.2015.3537","journal-title":"JAMA Neurol"},{"issue":"5","key":"4235_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mus.880100513","volume":"10","author":"K Mokuno","year":"1987","unstructured":"Mokuno K, Riku S, Sugimura K, Takahashi A, Kato K, Osugi S (1987) Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods. Muscle Nerve 10(5):459\u2013463. https:\/\/doi.org\/10.1002\/mus.880100513","journal-title":"Muscle Nerve"},{"issue":"3","key":"4235_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/ijns5030027","volume":"5","author":"A Timonen","year":"2019","unstructured":"Timonen A, Lloyd-Puryear M, Hougaard DM, Merio L, Makinen P, Laitala V, Polonen T, Skogstrand K, Kennedy A, Airenne S, Polari H, Korpimaki TD (2019) Duchenne muscular dystrophy newborn screening: evaluation of a new GSP((R)) neonatal creatine kinase-MM kit in a US and Danish population. Int J Neonatal Screen 5(3):27. https:\/\/doi.org\/10.3390\/ijns5030027","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"4235_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/ijns8010012","volume":"8","author":"BA Migliore","year":"2022","unstructured":"Migliore BA, Zhou L, Duparc M, Robles VR, Rehder CW, Peay HL, Kucera KS (2022) Evaluation of the GSP creatine kinase-MM assay and assessment of CK-MM stability in newborn, patient, and contrived dried blood spots for newborn screening for Duchenne muscular dystrophy. Int J Neonatal Screen 8(1):12. https:\/\/doi.org\/10.3390\/ijns8010012","journal-title":"Int J Neonatal Screen"},{"issue":"4","key":"4235_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1055\/s-0035-1558982","volume":"35","author":"JF Brandsema","year":"2015","unstructured":"Brandsema JF, Darras BT (2015) Dystrophinopathies. Semin Neurol 35(4):369\u2013384. https:\/\/doi.org\/10.1055\/s-0035-1558982","journal-title":"Semin Neurol"},{"issue":"12","key":"4235_CR21","doi-asserted-by":"publisher","first-page":"5448","DOI":"10.1210\/en.2004-0922","volume":"145","author":"M Santoro","year":"2004","unstructured":"Santoro M, Melillo RM, Carlomagno F, Vecchio G, Fusco A (2004) Minireview: RET: normal and abnormal functions. Endocrinology 145(12):5448\u20135451. https:\/\/doi.org\/10.1210\/en.2004-0922","journal-title":"Endocrinology"},{"issue":"1","key":"4235_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41467-018-08212-8","volume":"10","author":"D Menshykau","year":"2019","unstructured":"Menshykau D, Michos O, Lang C, Conrad L, McMahon AP, Iber D (2019) Image-based modeling of kidney branching morphogenesis reveals GDNF-RET based Turing-type mechanism and pattern-modulating WNT11 feedback. Nat Commun 10(1):239. https:\/\/doi.org\/10.1038\/s41467-018-08212-8","journal-title":"Nat Commun"},{"issue":"7","key":"4235_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41419-022-05031-0","volume":"13","author":"ER Rhymes","year":"2022","unstructured":"Rhymes ER, Tosolini AP, Fellows AD, Mahy W, McDonald NQ, Schiavo G (2022) Bimodal regulation of axonal transport by the GDNF-RET signalling axis in healthy and diseased motor neurons. Cell Death Dis 13(7):584. https:\/\/doi.org\/10.1038\/s41419-022-05031-0","journal-title":"Cell Death Dis"},{"key":"4235_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejmech.2018.02.080","volume":"150","author":"V La Pietra","year":"2018","unstructured":"La Pietra V, Sartini S, Botta L, Antonelli A, Ferrari SM, Fallahi P, Moriconi A, Coviello V, Quattrini L, Ke YY, Hsing-Pang H, Da Settimo F, Novellino E, La Motta C, Marinelli L (2018) Challenging clinically unresponsive medullary thyroid cancer: discovery and pharmacological activity of novel RET inhibitors. Eur J Med Chem 150:491\u2013505. https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.080","journal-title":"Eur J Med Chem"},{"issue":"1\u20132","key":"4235_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10735-006-9035-8","volume":"37","author":"C Yang","year":"2006","unstructured":"Yang C, Hutto D, Sah DW (2006) Distribution of GDNF family receptor alpha3 and RET in rat and human non-neural tissues. J Mol Histol 37(1\u20132):69\u201377. https:\/\/doi.org\/10.1007\/s10735-006-9035-8","journal-title":"J Mol Histol"},{"key":"4235_CR26","doi-asserted-by":"publisher","first-page":"e11405","DOI":"10.7554\/eLife.11405","volume":"5","author":"LA Moyle","year":"2016","unstructured":"Moyle LA, Blanc E, Jaka O, Prueller J, Banerji CR, Tedesco FS, Harridge SD, Knight RD, Zammit PS (2016) Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy. Elife 5:e11405. https:\/\/doi.org\/10.7554\/eLife.11405","journal-title":"Elife"},{"issue":"16","key":"4235_CR27","doi-asserted-by":"publisher","first-page":"9074","DOI":"10.3390\/ijms22169074","volume":"22","author":"R Klein","year":"2021","unstructured":"Klein R, Dardik R, Avishai E, Lalezari S, Barg AA, Levy-Mendelovich S, Budnik I, Barel O, Khavkin Y, Kenet G, Livnat T (2021) Molecular mechanisms of skewed X-chromosome inactivation in female hemophilia patients\u2014lessons from wide genome analyses. Int J Mol Sci 22(16):9074. https:\/\/doi.org\/10.3390\/ijms22169074","journal-title":"Int J Mol Sci"},{"issue":"23","key":"4235_CR28","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1073\/pnas.1507719112","volume":"112","author":"Y Hathout","year":"2016","unstructured":"Hathout Y, Brody E, Clemens PR, Cripe L, DeLisle RK, Furlong P, Gordish-Dressman H, Hache L, Henricson E, Hoffman EP, Kobayashi YM, Lorts A, Mah JK, McDonald C, Mehler B, Nelson S, Nikrad M, Singer B, Steele F, Sterling D, Sweeney HL, Williams S, Gold L (2016) Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy. Proc Natl Acad Sci USA 112(23):7153\u20137158. https:\/\/doi.org\/10.1073\/pnas.1507719112","journal-title":"Proc Natl Acad Sci USA"},{"key":"4235_CR29","doi-asserted-by":"publisher","first-page":"102060","DOI":"10.1016\/j.omtn.2023.102060","volume":"34","author":"N Shiba","year":"2023","unstructured":"Shiba N, Yang X, Sato M, Kadota S, Suzuki Y, Agata M, Nagamine K, Izumi M, Honda Y, Koganehira T, Kobayashi H, Ichimura H, Chuma S, Nakai J, Tohyama S, Fukuda K, Miyazaki D, Nakamura A, Shiba Y (2023) Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1. Mol Ther Nucleic Acids 34:102060. https:\/\/doi.org\/10.1016\/j.omtn.2023.102060","journal-title":"Mol Ther Nucleic Acids"},{"key":"4235_CR30","doi-asserted-by":"publisher","first-page":"175675","DOI":"10.1016\/j.ejphar.2023.175675","volume":"947","author":"G Patterson","year":"2023","unstructured":"Patterson G, Conner H, Groneman M, Blavo C, Parmar MS (2023) Duchenne muscular dystrophy: current treatment and emerging exon skipping and gene therapy approach. Eur J Pharmacol 947:175675. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175675","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"4235_CR31","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/cells12060908","volume":"12","author":"A Saoudi","year":"2023","unstructured":"Saoudi A, Fergus C, Gileadi T, Montanaro F, Morgan JE, Kelly VP, Tensorer T, Garcia L, Vaillend C, Muntoni F, Goyenvalle A (2023) Investigating the impact of delivery routes for exon skipping therapies in the CNS of DMD mouse models. Cells 12(6):908. https:\/\/doi.org\/10.3390\/cells12060908","journal-title":"Cells"},{"issue":"1","key":"4235_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00204-021-03184-z","volume":"96","author":"O Sheikh","year":"2022","unstructured":"Sheikh O, Yokota T (2022) Pharmacology and toxicology of eteplirsen and SRP-5051 for DMD exon 51 skipping: an update. Arch Toxicol 96(1):1\u20139. https:\/\/doi.org\/10.1007\/s00204-021-03184-z","journal-title":"Arch Toxicol"},{"issue":"1","key":"4235_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jsams.2008.08.004","volume":"13","author":"KR Lo","year":"2010","unstructured":"Lo KR, Hurst SM, Atkinson KR, Vandenbogaerde T, Beaven CM, Ingram JR (2010) Development and validation of a sensitive immunoassay for the skeletal muscle isoform of creatine kinase. J Sci Med Sport 13(1):117\u2013119. https:\/\/doi.org\/10.1016\/j.jsams.2008.08.004","journal-title":"J Sci Med Sport"},{"key":"4235_CR34","doi-asserted-by":"publisher","unstructured":"Subbiah V, Yang D, Velcheti V, Drilon A, Meric-Bernstam F (2020) State-of-the-art strategies for targeting RET-dependent cancers. J Clin Oncol 38(11): 1209\u20131221. https:\/\/doi.org\/10.1200\/JCO.19.02551.","DOI":"10.1200\/JCO.19.02551"},{"key":"4235_CR35","doi-asserted-by":"publisher","first-page":"101911","DOI":"10.1016\/j.ctrv.2019.101911","volume":"81","author":"AY Li","year":"2019","unstructured":"Li AY, McCusker MG, Russo A, Scilla KA, Gittens A, Arensmeyer K, Mehra R, Adamo V, Rolfo C (2019) RET fusions in solid tumors. Cancer Treat Rev 81:101911. https:\/\/doi.org\/10.1016\/j.ctrv.2019.101911","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"4235_CR36","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s42255-019-0110-3","volume":"1","author":"L Li","year":"2019","unstructured":"Li L, Rozo M, Yue S, Zheng X, Tan J, Lepper C, Fan CM (2019) Muscle stem cell renewal suppressed by Gas1 can be reversed by GDNF in mice. Nat Metab 1(10):985\u2013995. https:\/\/doi.org\/10.1038\/s42255-019-0110-3","journal-title":"Nat Metab"},{"issue":"8","key":"4235_CR37","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","volume":"26","author":"R Suriben","year":"2020","unstructured":"Suriben R, Chen M, Higbee J, Oeffinger J, Ventura R, Li B, Mondal K, Gao Z, Ayupova D, Taskar P, Li D, Starck SR, Chen HH, McEntee M, Katewa SD, Phung V, Wang M, Kekatpure A, Lakshminarasimhan D, White A, Olland A, Haldankar R, Solloway MJ, Hsu JY, Wang Y, Tang J, Lindhout DA, Allan BB (2020) Antibody-mediated inhibition of GDF15\u2013GFRAL activity reverses cancer cachexia in mice. Nat Med 26(8):1264\u20131270. https:\/\/doi.org\/10.1038\/s41591-020-0945-x","journal-title":"Nat Med"},{"issue":"4","key":"4235_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/embj.201284290","volume":"33","author":"P Klein","year":"2014","unstructured":"Klein P, Muller-Rischart AK, Motori E, Schonbauer C, Schnorrer F, Winklhofer KF (2014) Ret rescues mitochondrial morphology and muscle degeneration of Drosophila Pink1 mutants. EMBO J 33(4):341\u2013355. https:\/\/doi.org\/10.1002\/embj.201284290","journal-title":"EMBO J"},{"issue":"7","key":"4235_CR39","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1182\/blood.V95.7.2449","volume":"95","author":"K Christensen","year":"2000","unstructured":"Christensen K, Kristiansen M, Hagen-Larsen H, Skytthe A, Bathum L, Jeune B, Andersen-Ranberg K, Vaupel JW, Orstavik KH (2000) X-linked genetic factors regulate hematopoietic stem-cell kinetics in females. Blood 95(7):2449\u20132451. https:\/\/doi.org\/10.1182\/blood.V95.7.2449","journal-title":"Blood"},{"key":"4235_CR40","doi-asserted-by":"publisher","first-page":"e78263","DOI":"10.7554\/eLife.78263","volume":"11","author":"AL Roberts","year":"2022","unstructured":"Roberts AL, Morea A, Amar A, Zito A, El-Sayed Moustafa JS, Tomlinson M, Bowyer RCE, Zhang X, Christiansen C, Costeira R, Steves CJ, Mangino M, Bell JT, Wong CCY, Vyse TJ (2022) Age acquired skewed X chromosome inactivation is associated with adverse health outcomes in humans. Elife 11:e78263. https:\/\/doi.org\/10.7554\/eLife.78263","journal-title":"Elife"},{"issue":"2","key":"4235_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/s0960-8966(02)00213-4","volume":"13","author":"K Bushby","year":"2003","unstructured":"Bushby K, Muntoni F, Bourke JP (2003) 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord 13(2):166\u201372. https:\/\/doi.org\/10.1016\/s0960-8966(02)00213-4","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"4235_CR42","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1542\/peds.2005-2448","volume":"116","author":"American Academy of Pediatrics Section on Cardiology and Cardiac Surgery","year":"2005","unstructured":"American Academy of Pediatrics Section on Cardiology and Cardiac Surgery (2005) Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics 116(6):1569\u20131573. https:\/\/doi.org\/10.1542\/peds.2005-2448","journal-title":"Pediatrics"},{"issue":"8","key":"4235_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/pd.5473","volume":"39","author":"KS Small","year":"2019","unstructured":"Small KS, He WB, Du J, Xie PY, Zhou S, Zhang YX, Lu GX, Lin G, Li W, Tan YQ (2019) X-chromosome inactivation pattern of amniocytes predicts the risk of dystrophinopathy in fetal carriers of DMD mutations. Prenat Diagn 39(8):603\u2013608. https:\/\/doi.org\/10.1002\/pd.5473","journal-title":"Prenat Diagn"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04235-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04235-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04235-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T14:17:31Z","timestamp":1732285051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04235-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["4235"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04235-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,20]]},"assertion":[{"value":"1 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Nanjing Maternity and Child Health Care Hospital(Data: 2021\/No.: 2021KY-072).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}